Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
TRIAL OF A TOPICALLY ADMINISTERED LOCAL-ANESTHETIC (EMLA CREAM) FOR PAIN RELIEF DURING CENTRAL VENOUS PORT ACCESSES IN CHILDREN WITH CANCER
Autore:
MISER AW; GOH TS; DOSE AM; OFALLON JR; NIEDRINGHAUS RD; BETCHER DL; SIMMONS P; MACKELLAR DJ; ARNOLD M; LOPRINZI CL;
Indirizzi:
MAYO CLIN & MAYO FDN,DIV MED ONCOL,200 1ST ST SW ROCHESTER MN 55905 MAYO CLIN & MAYO FDN,DIV MED ONCOL ROCHESTER MN 55905 MAYO CLIN & MAYO FDN,DIV CANC STAT ROCHESTER MN 55905 ALLAN BLAIR MEM CLIN,SASKATCHEWAN CANC FDN REGINA SK CANADA DULUTH COMMUNITY CLIN ONCOL PROGRAM DULUTH MN 00000 SIOUX COMMUNITY CANC CONSORTIUM SIOUX FALLS SD 00000 ST LUKES HOSP,CCOP FARGO ND 00000 IOWA ONCOL RES ASSOC,CCOP DES MOINES IA 00000
Titolo Testata:
Journal of pain and symptom management
fascicolo: 4, volume: 9, anno: 1994,
pagine: 259 - 264
SICI:
0885-3924(1994)9:4<259:TOATAL>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
LIDOCAINE-PRILOCAINE CREAM; VENIPUNCTURE; LIGNOCAINE;
Keywords:
PROCEDURE-RELATED PAIN; CHILDREN; CYTOTOXIC CHEMOTHERAPY; EMLA CREAM;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
15
Recensione:
Indirizzi per estratti:
Citazione:
A.W. Miser et al., "TRIAL OF A TOPICALLY ADMINISTERED LOCAL-ANESTHETIC (EMLA CREAM) FOR PAIN RELIEF DURING CENTRAL VENOUS PORT ACCESSES IN CHILDREN WITH CANCER", Journal of pain and symptom management, 9(4), 1994, pp. 259-264

Abstract

Procedure-related pain is a significant problem for many children receiving cytotoxic chemotherapy. In an effort to lessen this toxicity, we studied the efficacy and safely of administering topical local anesthesia using EMLA cream in 47 evaluable children with cancer undergoingimplanted central venous po?t injections. Children (< 21 years old) scheduled to undergo repeated venous access procedures were selected for study. A placebo-controlled, randomized, double-blind crossover study design was utilized. Statistically significant decreases in pain intensity scores (P < 0.002) were recorded by both children and investigators during the use of EMLA cream as compared with placebo. There was a good correlation between pain scores recorded by both patients and health care providers using both visual analog scales and categorized pain measurement tools. The topical application of EMLA cream 5% provides highly effective superficial anesthesia, and promises to be extremely useful for pain relief during percutaneous access procedures in cancer patients.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/11/20 alle ore 08:56:19